Fulvestrant (‘Faslodex’) in clinical practice: International experience from a Compassionate Use Programme
No abstract is available. To read the body of this article, please view the Full Text online.
To access this article, please choose from the options below
PII: S0305-7372(05)00144-1
doi:10.1016/j.ctrv.2005.08.006
© 2005 Elsevier Ltd. All rights reserved.
